An unusual cause of high anion gap metabolic acidosis: pyroglutamic acidemia. A case report.

Détails

ID Serval
serval:BIB_93975F022230
Type
Actes de conférence (partie): contribution originale à la littérature scientifique, publiée à l'occasion de conférences scientifiques, dans un ouvrage de compte-rendu (proceedings), ou dans l'édition spéciale d'un journal reconnu (conference proceedings).
Sous-type
Abstract (résumé de présentation): article court qui reprend les éléments essentiels présentés à l'occasion d'une conférence scientifique dans un poster ou lors d'une intervention orale.
Collection
Publications
Institution
Titre
An unusual cause of high anion gap metabolic acidosis: pyroglutamic acidemia. A case report.
Titre de la conférence
83e assemblée annuelle 2015 de la Société Suisse de Médecine Interne Générale (SSMI)
Auteur⸱e⸱s
Gachoud D., Metrailler P., Martiz Aguilar A., Vollenweider P.
Adresse
Publication types: Case Reports ; Journal Article Publication Status: ppublish 83e assemblée annuelle 2015 de la Société Suisse de Médecine Interne Générale (SSMI), in
Publication types: Case Reports ; Journal Article Publication Status: ppublish
83e assemblée annuelle 2015 de la Société Suisse de Médecine Interne Générale (SSMI), in Praxis 2015; 104 : Suppl 1, p.86
Gachoud D.
Metrailler P.
Martiz Aguilar A.
Vollenweider P.
ISBN
1536-3686 (Electronic)
ISSN-L
1075-2765
Statut éditorial
Publié
Date de publication
2015
Volume
104
Série
Praxis
Pages
86
Langue
anglais
Résumé
Pyroglutamic acidemia is an uncommon metabolic disorder, which is usually diagnosed at early ages. The mechanism of action is thought to be glutathione depletion, and its clinical manifestations consist of hemolytic anemia, mental retardation, ataxia, and chronic metabolic acidosis. However, an acquired form has been described in adult patients, who usually present with confusion, respiratory distress, and high anion gap metabolic acidosis (HAGMA). It is also associated with many conditions, including chronic acetaminophen consumption. A 68-year-old white male, with chronic acetaminophen use presented to our service on multiple occasions with severe HAGMA. The patient was admitted to the intensive care unit and required mechanical ventilation and aggressive supportive measures. After ruling out the most frequent etiologies for his acid-base disorder and considering the long history of Tylenol ingestion, his 5-oxiproline (pyroglutamic acid) levels were sent to diagnose pyroglutamic acidemia. Clinicians need to be aware of this cause for metabolic acidosis since it might be a more common metabolic disturbance in compromised patients than would be expected. Subjects with HAGMA that cannot be explained by common causes should be tested for the presence of 5-oxoproline. Discontinuation of the offending drug is therapeutic.
Mots-clé
Acetaminophen/administration & dosage, Acidosis/diagnosis, Acidosis/epidemiology, Acute Kidney Injury/epidemiology, Aged, Analgesics, Non-Narcotic/administration & dosage, Humans, Male, Pyrrolidonecarboxylic Acid/blood
Création de la notice
26/01/2016 12:00
Dernière modification de la notice
20/08/2019 15:56
Données d'usage